RecruitingNot ApplicableNCT04929899
Bright Ideas - CIN Feasibility Study
Improving Chemotherapy-induced Nausea Control Through Bright Ideas®-CIN Training: a Feasibility Study in Children Receiving Oral Chemotherapy
Sponsor
The Hospital for Sick Children
Enrollment
75 participants
Start Date
Mar 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Eligibility
Min Age: 4 YearsMax Age: 18 Years
Inclusion Criteria6
- Age: ≥ 4 years (PeNAT validated in patients 4 to 18 yrs)
- newly diagnosed or recurrent disease: first diagnosis of ALL (i.e. non-relapsed) in maintenance therapy
- English, French or Spanish-speaking with an English, French or Spanish-speaking guardian (PeNAT available in these languages)
- without physical or cognitive impairments that preclude use of the PeNAT
- planned to receive PO 6-mercaptopurine
- not planned to receive IV, IM, SC or IT chemotherapy or oral or IV corticosteroids during the 7-day study period
Interventions
BEHAVIORALBright Ideas - CIN Training
Bright IDEAS is a validated problem-solving skill training intervention.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04929899
Related Trials
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
NCT0359017115 locations
Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
NCT071911191 location
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
NCT01351545142 locations
Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.
NCT073271381 location
Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia
NCT073269303 locations